Pharma

Your Article Summary

See Latest Articles

New post-hoc, pooled analysis shows SYMBICORT improved airflow obstruction in patients with COPD
AstraZeneca, 11/10/09

A new post–hoc, pooled analysis of the serial spirometry subset of the pivotal efficacy and safety trials, SHINE and SUN, demonstrated that a large percentage of patients with moderate to very severe Chronic Obstructive Pulmonary Disease receiving two inhalations of SYMBICORT Inhalation Aerosol 160/4.5 mcg showed improvement of airflow obstruction on day of randomization, as evidenced by the American Thoracic Society criteria.

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09

FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09

Gyrus PlasmaKinetic bipolar coagulation device for liver resection
Australian and New Zealand Journal of Surgery, 11/13/09

See All of Medical Devices/Products

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09

Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09

Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09

See All of Research & Development